PetMed Express, Inc.

PETS

US7163821066

Drug Retailers

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-18 pm EDT			5-day change	1st Jan Change
4.11 ^USD	-2.61%		-0.72%	-45.63%

Apr. 15	Earnings Flash (PETS) PETMED EXPRESS Posts Q3 Revenue $65.3M	MT
Apr. 15	PetMed Express, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	CI

PetMed: Fiscal Q3 Earnings Snapshot

January 24, 2022 at 04:18 pm EST

DELRAY BEACH, Fla. (AP) _ PetMed Express Inc. (PETS) on Monday reported net income of $4.3 million in its fiscal third quarter.

The Delray Beach, Florida-based company said it had net income of 21 cents per share.

The pet pharmacy company posted revenue of $60.7 million in the period.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on PETS at https://www.zacks.com/ap/PETS

Latest news about PetMed Express, Inc.

Earnings Flash (PETS) PETMED EXPRESS Posts Q3 Revenue $65.3M	Apr. 15	MT
PetMed Express, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	Apr. 15	CI
PetMed Express, Inc.(NasdaqGS:PETS) dropped from NASDAQ Internet Index	Mar. 14	CI
Transcript : PetMed Express, Inc., Q3 2024 Earnings Call, Feb 08, 2024	Feb. 08
PetMed Express Names Leslie C. G. Campbell Chairman	Jan. 09	MT
PetMed Express, Inc. Announces Management Changes	Jan. 08	CI
Morgan Stanley Trims Price Target on PetMed Express to $6.50 From $7, Keeps Underweight Rating	Nov. 16	MT
Petmed Express Insider Bought Shares Worth $301,125, According to a Recent SEC Filing	Nov. 13	MT
Petmed Express Insider Bought Shares Worth $100,551, According to a Recent SEC Filing	Nov. 07	MT
Tranche Update on PetMed Express, Inc.'s Equity Buyback Plan announced on August 1, 2011.	23-10-31	CI
Traders Eye Fed Meeting for Fresh Cues as US Equity Futures Edge Higher Pre-Bell	23-10-31	MT
Morgan Stanley Cuts Price Target on PetMed Express to $7 From $10 After Fiscal Q2 Miss, Keeps Underweight Rating	23-10-31	MT
Top Premarket Decliners	23-10-31	MT
Transcript : PetMed Express, Inc., Q2 2024 Earnings Call, Oct 30, 2023	23-10-30
Earnings Flash (PETS) PETMED EXPRESS Reports Q2 Revenue $71M, vs. Street Est of $76M	23-10-30	MT
PetMed Express, Inc. Makes Decision to Suspend the Quarterly Dividend Effective the Quarter Ended September 30, 2023	23-10-30	CI
PetMed Express, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	23-10-30	CI
Morgan Stanley Adjusts Price Target on PetMed Express to $10 From $17, Maintains Underweight Rating	23-10-19	MT
PetMed Express Partners With Pumpkin Insurance to Offer Pet Insurance	23-10-13	MT
PetMed Express, Inc Teams Up with Pumpkin® to Help Make Pet Care Simple and Affordable	23-10-12	CI
PetMed Express, Inc.(NasdaqGS:PETS) dropped from S&P Retail Select Industry Index	23-09-18	CI
Janover Names Bruce Rosenbloom Chief Financial Officer	23-09-07	MT
Tranche Update on PetMed Express, Inc.'s Equity Buyback Plan announced on August 1, 2011.	23-08-02	CI
Transcript : PetMed Express, Inc., Q1 2024 Earnings Call, Jul 31, 2023	23-07-31
Earnings Flash (PETS) PETMED EXPRESS Posts Q1 Revenue $78.2M, vs. Street Est of $79.9M	23-07-31	MT

PetMed Express, Inc., doing business as PetMeds, is a direct-to-consumer pet pharmacy. The Company is an online provider of prescription and non-prescription medications, food, supplements, supplies and vet services for dogs, cats, and horses. It markets and sells directly to consumers through its websites, toll-free numbers, and mobile applications. Its product line contains approximately 15,000 SKUs of pet medications, health products, and supplies. The Company offers various pet supplies, including food, beds, crates, stairs and other pet supplies. PetMeds products include Non-Prescription Medications (OTC) and supplies, and Prescription Medications (Rx). OTC and supplies include flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies. Rx includes heartworm and flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications.

Sector

Drug Retailers

Calendar

2024-05-05 - Q4 2024 Earnings Release (Projected)

Related indices

Russell 2000

More about the company

Income Statement Evolution

More financial data

Ratings for PetMed Express, Inc.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

4.11 USD

Average target price

7.75 USD

Spread / Average Target

+88.56%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Retail - Drugs without Grocery

	1st Jan change	Capi.
PETMED EXPRESS, INC.	-45.63%	83.83M
RAIA DROGASIL S.A.	-15.31%	8.11B
AIN HOLDINGS INC.	+31.63%	1.34B
QOL HOLDINGS CO., LTD.	+2.78%	419M
NIHON CHOUZAI CO.,LTD.	+7.72%	299M
SALUS, LJUBLJANA, D. D.	+14.44%	231M
GREEN CROSS HEALTH LIMITED	-4.59%	88.36M
MEDICAL IKKOU GROUP CO.,LTD.	+18.81%	59.48M

Retail - Drugs without Grocery

PetMed Express, Inc.

Equities

PETS

US7163821066

Drug Retailers

PetMed: Fiscal Q3 Earnings Snapshot

Latest news about PetMed Express, Inc.

Chart PetMed Express, Inc.

Company Profile

Income Statement Evolution

Ratings for PetMed Express, Inc.

Analysts' Consensus

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Retail - Drugs without Grocery